Chitosan coated furosemide liposomes for improved bioavailability

Journal of Biomedical Nanotechnology

Volumn 7, Issue 3, 2011, Pages 426-430

  Vural, Imran ^a   Sarisozen, Can ^a   Olmez, Senem Sevtap ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Caco 2; Chitosan; Furosemide; Liposomes; MTT; Permeability

Indexed keywords

CACO-2; CACO-2 CELLS; CELL VIABILITY; CYTOTOXIC EFFECTS; ENCAPSULATION EFFICIENCY; FUROSEMIDES; MTT; ORAL ADMINISTRATION; POORLY SOLUBLE DRUGS;

BIOCHEMISTRY; CELL CULTURE; CELLS; CHITOSAN; CYTOTOXICITY; ENCAPSULATION; LIPOSOMES; MECHANICAL PERMEABILITY; ZETA POTENTIAL;

PHOSPHOLIPIDS;

CHITOSAN; FUROSEMIDE; LIPOSOME; DIURETIC AGENT;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG PENETRATION; NANOENCAPSULATION; PARTICLE SIZE; ZETA POTENTIAL; BIOAVAILABILITY; CELL STRAIN CACO 2; CELL SURVIVAL; CHEMISTRY; HUMAN; SURFACE PROPERTY;

BIOLOGICAL AVAILABILITY; CACO-2 CELLS; CELL SURVIVAL; CHITOSAN; DIURETICS; FUROSEMIDE; HUMANS; LIPOSOMES; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 80052338818     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1294     Document Type: Article

References (30)

1. L. L. Ponto and R. D. Schoenwald, Furosemide (frusemide) a pharmacokinetic/pharmacodynamic review (Part I). Clin Pharmacokinet. 18, 381 (1990).
2. L. L. Ponto and R. D. Schoenwald, Furosemide (frusemide) a pharmacokinetic/pharmacodynamic review (Part II). Clin Pharmacokinet. 18, 460 (1990).
3. G. E. Granero, M. R. Longhi, M. J. Mora, H. E. Junginger, K. K. Midha, V. P. Shah, S. Stavchansky, J. Dressman, and D. M. Barends, Biowaiver monographs for immediate release solid oral dosage forms: Furosemide. J. Pharm. Sci. 99, 2544 (2010).
4. G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. A. Crison, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413 (1995).
5. M. J. Ruiz-Angel, A. Berthod, S. Carda-Broch, and M. C. Garcia- Alvarez-Coque, Analytical techniques for furosemide determination. Separation & Purification Reviews 35, 39 (2006).
6. M. B. Bindu, B. Kusum, and D. Banji, Novel startegies for poorly water soluble drugs. Int. J. Pharm. Sci. Rev. Res. 4, 76 (2010).
7. V. R. Vemula, V. Lagishetty1, and S. Lingala, Solubility enhancement techniques. Int. J. Pharm. Sci. Rev. Res. 5, 41 (2010).
8. A. J. Humberstone and W. N. Charman, Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25, 103 (1997).
9. D. A. Bhatt and A. M. Pethe, Lipid technology - A promising drug delivery system for poorly water soluble drugs. Int. J. Pharmaceut. Res. Dev. 2, 1 (2010).
10. C. J. H. Porter, N. L. Trevaskis, and W. N. Charman, Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6, 231 (2007).
11. B. A. Khaw, V. P. Torchilin, I. Vural, and J. Narula, Plug and seal: Prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin liposomes. Nat. Med. 1, 1195 (1995).
12. B. A. Khaw, J. DaSilva, I. Vural, J. Narula, and V. P. Torchilin, Intracytoplasmic gene delivery for in vitro transfection with cytoskeletonspecific immunoliposomes. J. Control. Release 10, 199 (2001).
13. M. A. Rouf, I. Vural, J. M. Renoir, and A. A. Hincal, Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells. J. Liposome Res. 19, 322 (2009).
14. J. Guo, Q. Ping, G. Jiang, L. Huang, and Y. Tong, Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int. J. Pharm. 260, 167 (2003).
15. S. M. Carballo, A. O. Vila, M. Sibaja, J. D. Reed, and F. Molina, In vitro uptake of lysozyme-loaded liposomes coated with chitosan biopolymer as model immunoadjuvants. J. Liposome Res. 20, 1 (2010).
16. S. M. Carballo, G. Rodriguez, M. Sibaja, J. D. Reed, A. O. Vila, and F. Molina, Chitosomes loaded with cranberry proanthocyanidins attenuate the bacterial lipopolysaccharide-induced expression of iNOS and COX-2 in raw 264.7 macrophages. J. Liposome Res. 19, 189 (2009).
17. M. J. Kim, D. H. Jang, H. J. Lee, and Y. H. Choa, A study on the characterization and stability of rhenium(III) chloride-incorporated liposomes. Res. Chem. Intermediates. 36, 725 (2010).
18. M. Prabaharan and J. F. Mano, Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 12, 41 (2005).
19. I. Vural, H. S. Kas, and A. A. Hincal, Chitosan-treated albumin microspheres of sulfasalazine. H.U. J. Fac. Pharm. 14, 57 (1994).
20. S. S. Olmez, P. Korkusuz, H. Bilgili, and S. Senel, Chitosan and alginate scaffolds for bone tissue regeneration. Pharmazie. 62, 423 (2007).
21. H. C. Arca, M. Gunbeyaz, and S. Senel, Chitosan-based systems for the delivery of vaccine antigens. Expert Rev. Vaccines. 8, 937 (2009).
22. J. Filipoviccic, N. Skalko-Basnet, and I. Jalsenjak, Mucoadhesive chitosan-coated liposomes: Characteristics and stability. J. Microencapsulation 18, 3 (2001).
23. H. Takeuchi, Y. Matsui, H. Sugihara, H. Yamamoto, and Y. Kawashima, Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int. J. Pharm. 303, 160 (2005).
24. J. Cao, J. Sun, X. Wang, X. Li, and Y. Deng, N-Trimethyl chitosan coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev. Ind. Pharm. 35, 1339 (2009).
25. J. R. Miller, Penetration of furosemide into phospholipid monolayers. J. Membrane Biol. 101, 113 (1988).
26. D. Bach, C. Vinkler, I. R. Miller, and S. R. Caplan, Interaction of furosemide with lipid membranes. J. Membrane Biol. 101, 103 (1988).
27. M. M. Mady, M. M. Darwish, S. Khalil, and W. M. Khalil, Biophysical studies on chitosan coated liposomes. Eur. Biophys. J. 38, 1127 (2009).
28. M. C. Berrocal, J. Bujan, F. Jurado, and A. Abeger, Aging of soya-PC liposomes containing vitamin E reverses the stimulating effects of freshly prepared liposomes on growth of fibroblasts in culture. Drug Deliv. 5, 243 (1998).
29. M. C. Berrocal, J. Bujan, F. Jurado, and A. Abeger, Comparison of the effects of dimyristoyl and soya phosphatidylcholine liposomes on human fibroblasts. Drug Deliv. 7, 37 (2000).
30. C. M. Silva, F. Veiga, A. J. Ribeiro, N. Zerrouk, and P. Arnaud, Effect of Chitosan coated alginate microspheres on the permeability of Caco-2 cell monolayers. Drug Dev. Ind. Pharm. 32, 1079 (2006).